Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Lumentum Holdings Inc.
LITE
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By geography
See full
EMEA
6.5%
-34.3%
Other Asia-Pacific
6.5%
-30.1%
Other Americas
0.2%
-86.7%
By segment
See full
Components
66%
—
Systems
34%
—
Other financials
Income statement
See full
Revenue
$808.4M
+90.1%
Gross profit
$376.3M
+166%
Operating income
$174.5M
+563%
Net income
$144.2M
+427%
EPS (diluted)
$1.50
+334%
Balance sheet
See full
Cash & equivalents
$517.7M
+45.8%
Total debt
$6.6B
+150%
Total equity
$3.0B
+238%
Total assets
$7.0B
+76.8%
Cash flow
See full
Operating cash flow
$203.8M
—
CapEx
$124.7M
+98.6%
Free cash flow
$79.1M
+223%
Valuation
See full
Market cap
$67.06B
+978%
Enterprise value
$73.1B
+761%
P/E
152.5×
—
P/S
27×
+22.7×
Profitability
See full
Gross margin
40.8%
+11.2pp
Operating margin
9.5%
+5.7pp
Net margin
17.7%
+10.9pp
FCF margin
4.2%
—
Returns & leverage
See full
Return on equity
22.8%
+13.8pp
Debt / equity
2.2×
-0.8×
Current ratio
1.1×
-3.6×